The DOI matches its Crossref record; 382 of the 382 references it cites were found in a registry or an index.
The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies
Open accessAbstract
The therapeutic potential of calorie restriction and the ketogenic diet have been repeatedly demonstrated in clinical settings and in various animal models of neurological disease. The underlying mechanisms involve an improvement in mitochondrial function, a decrease in the expression of apoptotic factors and an increase in the activity of neurotrophic factors. Clinical applications of ketogenic diets have been significantly hampered however by poor tolerability and potentially serious side-effects. Recent research aimed at identifying a mediator that can reproduce the neuroprotective effects of calorie restriction with less demanding changes to dietary intake suggests that ketone bodies might represent an appropriate candidate. Ketone bodies protect neurons against multiple types of neuronal injury and the underlying mechanisms are similar to those of calorie restriction and of the ketogenic diet. The present review describes the neuroprotective effects of calorie restriction, the ketogenic diet and ketone bodies and compare the molecular mechanisms of action of these interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mitochondrial formation of reactive oxygen species
Turrens, J. F. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.049478 · Cited by 5,084
Mitochondria, Oxidants, and Aging
Balaban, R. S., Nemoto, S., & Finkel, T. (2005) · Cell · doi:10.1016/j.cell.2005.02.001 · Cited by 4,388
Resveratrol improves health and survival of mice on a high-calorie diet
Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., Kalra, A., Prabhu, V. V., Allard, J. S., Lopez-Lluch, G., Lewis, K., et al. (2006) · Nature · doi:10.1038/nature05354 · Cited by 4,290
Neurodegenerative diseases and oxidative stress
Barnham, K. J., Masters, C. L., & Bush, A. I. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1330 · Cited by 3,683
Mitochondrial membrane permeabilization in cell death
Kroemer, G., Galluzzi, L., & Brenner, C. (2007) · Physiological Reviews · doi:10.1152/physrev.00013.2006 · Cited by 3,598 · cited 1×
“Protein phosphatase 2A is a serine-threonine protease enzyme that can trigger apoptosis by inactivating the anti-apoptotic factor Bcl2, an inhibitor of mitochondrial permeability transition (Virshup 2000; Janssens and Goris 2001; Dagda et al., 2003; Kroemer et al., 2007).”
BackgroundNuclear factor-κB in cancer development and progression
Karin, M. (2006) · Nature · doi:10.1038/nature04870 · Cited by 3,519 · cited 15×
“Calorie restriction reduces NFκB levels (probably through a Sirt1-dependent process), blocks the synthesis of interleukins and TNFα and suppresses the activity of COX-2 and iNOS in animalmodels and in humans (Spaulding et al., 1997; Clement et al., 2004; Bhattacharya et al., 2006; Kalani et al., 2006; Kim et al., 2006…”
BackgroundInfluentialTranscriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase
Imai, S.-I., Armstrong, C. M., Kaeberlein, M., & Guarente, L. (2000) · Nature · doi:10.1038/35001622 · Cited by 3,510 · cited 1×
“Sir2 is a class III histone deacetylase that uses the cofactor nicotinamide adenine dinucleotide (NAD+) in a catalytic reaction that releases nicotinamide (a feedback inhibitor) and O-acetyl ADP ribose (Imai et al., 2000; Marmorstein, 2004; Sauve et al., 2006).”
BackgroundThe Pathophysiology of Mitochondrial Cell Death
Green, D. R., & Kroemer, G. (2004) · Science · doi:10.1126/science.1099320 · Cited by 3,418
Molecular Chaperones in the Cytosol: from Nascent Chain to Folded Protein
Hartl, F. U., & Hayer-Hartl, M. (2002) · Science · doi:10.1126/science.1068408 · Cited by 3,347
Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase
Brunet, A., Sweeney, L. B., Sturgill, J. F., Chua, K. F., Greer, P. L., Lin, Y., Tran, H., Ross, S. E., Mostoslavsky, R., Cohen, H. Y., et al. (2004) · Science · doi:10.1126/science.1094637 · Cited by 3,239
Cited by
Neural mechanisms of ageing and cognitive decline
Bishop, N. A., Lu, T., & Yankner, B. A. (2010) · Nature · doi:10.1038/nature08983 · Cited by 1,323
Beyond weight loss: a review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets
Paoli, A., Rubini, A., Volek, J. S., & Grimaldi, K. A. (2013) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2013.116 · Cited by 885
Sleiman, S. F., Henry, J., Al-Haddad, R., El Hayek, L., Abou Haidar, E., Stringer, T., Ulja, D., Karuppagounder, S. S., Holson, E. B., Ratan, R. R., et al. (2016) · eLife · doi:10.7554/elife.15092 · Cited by 810
The effects of aging in the hippocampus and cognitive decline
Bettio, L. E. B., Rajendran, L., & Gil-Mohapel, J. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.04.030 · Cited by 649
Henderson, S. T., Vogel, J. L., Barr, L. J., Garvin, F., Jones, J. J., & Costantini, L. C. (2009) · Nutrition & Metabolism · doi:10.1186/1743-7075-6-31 · Cited by 548
The Ketogenic Diet as a Treatment Paradigm for Diverse Neurological Disorders
Stafstrom, C. E., & Rho, J. M. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00059 · Cited by 438
Self-citationEnergy intake and exercise as determinants of brain health and vulnerability to injury and disease
Mattson, M. P. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.08.012 · Cited by 434
Self-citationThe nexus of chromatin regulation and intermediary metabolism
Gut, P., & Verdin, E. (2013) · Nature · doi:10.1038/nature12752 · Cited by 421
Kashiwaya, Y., Bergman, C., Lee, J.-H., Wan, R., King, M. T., Mughal, M. R., Okun, E., Clarke, K., Mattson, M. P., & Veech, R. L. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.11.023 · Cited by 363
“Previous studies have demonstrated a positive association between levels of endogenous ketone bodies and cognitive function in human subjects and animal models (see Maalouf et al., 2009 for a review).”
ResultSelf-citationDietary ketosis enhances memory in mild cognitive impairment
Krikorian, R., Shidler, M. D., Dangelo, K., Couch, S. C., Benoit, S. C., & Clegg, D. J. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.10.006 · Cited by 361
A high-fat diet and NAD(+) activate Sirt1 to rescue premature aging in Cockayne syndrome
Scheibye-Knudsen, M., Mitchell, S. J., Fang, E. F., Iyama, T., Ward, T., Wang, J., Dunn, C. A., Singh, N., Veith, S., Hasan-Olive, M. M., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.10.005 · Cited by 352
Self-citationNeuronal Calcium Homeostasis and Dysregulation
Gleichmann, M., & Mattson, M. P. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3386 · Cited by 360
“One such intervention, the ketogenic diet for epilepsy, is a reminder that such approaches are possible in principle, although the underlying mechanisms are poorly understood at the molecular level (59).”
BackgroundSelf-citationKetogenic Diet in Alzheimer’s Disease
Rusek, M., Pluta, R., Ułamek-Kozioł, M., & Czuczwar, S. J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20163892 · Cited by 319
Regulation of Ketone Body Metabolism and the Role of PPARα
Grabacka, M., Pierzchalska, M., Dean, M., & Reiss, K. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17122093 · Cited by 305
Role of ketogenic diets in neurodegenerative diseases (Alzheimer's disease and Parkinson's disease)
Włodarek, D. (2019) · Nutrients · doi:10.3390/nu11010169 · Cited by 301
Zuccoli, G., Marcello, N., Pisanello, A., Servadei, F., Vaccaro, S., Mukherjee, P., & Seyfried, T. N. (2010) · Nutrition & Metabolism · doi:10.1186/1743-7075-7-33 · Cited by 267
Ułamek-Kozioł, M., Czuczwar, S. J., Januszewski, S., & Pluta, R. (2019) · Nutrients · doi:10.3390/nu11102510 · Cited by 266
Raefsky, S. M., & Mattson, M. P. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.11.045 · Cited by 257
Self-citationMarosi, K., Kim, S. W., Moehl, K., Scheibye‐Knudsen, M., Cheng, A., Cutler, R., Camandola, S., & Mattson, M. P. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13868 · Cited by 242
“However, the ability of ketogenic diets (Gasior et al. 2006; Maalouf et al. 2009) and 3OHB supplementation (Kashiwaya et al.”
BackgroundInfluentialSelf-citationKetogenic diet decreases oxidative stress and improves mitochondrial respiratory complex activity
Greco, T., Glenn, T. C., Hovda, D. A., & Prins, M. L. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x15610584 · Cited by 210
Chidambaram, S. B., Essa, M. M., Rathipriya, A. G., Bishir, M., Ray, B., Mahalakshmi, A. M., Tousif, A. H., Sakharkar, M. K., Kashyap, R. S., Friedland, R. P., et al. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107988 · Cited by 204
Rothman, S. M., Griffioen, K. J., Wan, R., & Mattson, M. P. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06525.x · Cited by 185
Self-citationYao, J., Chen, S., Mao, Z., Cadenas, E., & Brinton, R. D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021788 · Cited by 169
“Caloric restriction has been widely documented to increase expression of stress-response genes, such as Manganese Superoxide Dismutase (MnSOD) and heat shock proteins (HSPs)[50,51], whereas in this study we observed a significant decrease in MnSOD expression and activity and a decrease in Hsp60 expression, via a mecha…”
BackgroundDiet in Parkinson’s Disease: Critical Role for the Microbiome
Jackson, A., Forsyth, C. B., Shaikh, M., Voigt, R. M., Engen, P. A., Ramirez, V., & Keshavarzian, A. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.01245 · Cited by 145
The Current Status of the Ketogenic Diet in Psychiatry
Bostock, E. C. S., Kirkby, K. C., & Taylor, B. V. M. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00043 · Cited by 127
“The therapeutic advantage of KD has been replicated in animal models of neurological illnesses, and the purported underlying mechanisms include those which improve mitochondrial function (27).”
BackgroundChaperone-mediated autophagy. Machinery, regulation and biological consequences
Li, W., Yang, Q., & Mao, Z. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0565-6 · Cited by 119
Fujitsuka, N., Asakawa, A., Morinaga, A., Amitani, M. S., Amitani, H., Katsuura, G., Sawada, Y., Sudo, Y., Uezono, Y., Mochiki, E., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.220 · Cited by 114
Peng, Y., Gao, P., Shi, L., Chen, L., Liu, J., & Long, J. (2020) · Antioxidants & Redox Signaling · doi:10.1089/ars.2019.7763 · Cited by 110
Neuroprotective effects of dietary restriction: Evidence and mechanisms
Pani, G. (2015) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2015.03.004 · Cited by 103
The ketogenic diet preserves skeletal muscle with aging in mice
Wallace, M. A., Aguirre, N. W., Marcotte, G. R., Marshall, A. G., Baehr, L. M., Hughes, D. C., Hamilton, K. L., Roberts, M. N., Lopez‐Dominguez, J. A., Miller, B. F., et al. (2021) · Aging Cell · doi:10.1111/acel.13322 · Cited by 93
Caloric restriction increases ketone bodies metabolism and preserves blood flow in aging brain
Lin, A.-L., Zhang, W., Gao, X., & Watts, L. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.03.012 · Cited by 90
Mulrooney, T. J., Marsh, J., Urits, I., Seyfried, T. N., & Mukherjee, P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018085 · Cited by 75
“CR is known to reduce circulating level of glucose and to elevate the levels of ketone bodies [22,60,86,87].”
BackgroundPopov, A., Denisov, P., Bychkov, M., Brazhe, A., Lyukmanova, E., Shenkarev, Z., Lazareva, N., Verkhratsky, A., & Semyanov, A. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-2406-3 · Cited by 72
Ketogenic diets and Alzheimer’s disease
Lange, K. W., Lange, K. M., Makulska-Gertruda, E., Nakamura, Y., Reissmann, A., Kanaya, S., & Hauser, J. (2017) · Food Science and Human Wellness · doi:10.1016/j.fshw.2016.10.003 · Cited by 56
Mychasiuk, R., & Rho, J. M. (2017) · Autism Research · doi:10.1002/aur.1682 · Cited by 45
Self-citationMitochondria-Targeted Therapeutics for Alzheimer's Disease: The Good, the Bad, the Potential
Mi, Y., Qi, G., Brinton, R. D., & Yin, F. (2021) · Antioxidants & Redox Signaling · doi:10.1089/ars.2020.8070 · Cited by 43
The role of suboptimal mitochondrial function in vulnerability to post‐traumatic stress disorder
Preston, G., Kirdar, F., & Kozicz, T. (2018) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-018-0168-1 · Cited by 36
Effect of Ketogenic Diet on Obesity and Other Metabolic Disorders: Narrative Review
Baylie, T., Ayelgn, T., Tiruneh, M., & Tesfa, K. (2024) · Diabetes, Metabolic Syndrome and Obesity · doi:10.2147/dmso.s447659 · Cited by 27
“53,54 In many studies, the KD has shown hopeful results in a variety of metabolic disorders such as T2DM, NAFLD, PCOS and CVD. 56 KDs have positive effects on several risk factors for cardiovascular disease.”
BackgroundIntermittent Fasting: Myths, Fakes and Truth on This Dietary Regimen Approach
Brogi, S., Tabanelli, R., Puca, S., & Calderone, V. (2024) · Foods · doi:10.3390/foods13131960 · Cited by 26
Intermittent Fasting: Myths, Fakes and Truth on this Dietary Regimen Approach
Brogi, S., Tabanelli, R., Puca, S., & Calderone, V. (2024) · doi:10.20944/preprints202405.1820.v1 · Cited by 26
Biesiekierska, M., Strigini, M., Śliwińska, A., Pirola, L., & Balcerczyk, A. (2025) · Nutrition Reviews · doi:10.1093/nutrit/nuaf010 · Cited by 18
The control of mitochondrial succinate-dependent H2O2 production
Zoccarato, F., Miotto, C., Cavallini, L., & Alexandre, A. (2011) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-011-9363-6 · Cited by 8
Metadata
- Authors
- Maalouf, M., Rho, J. M., & Mattson, M. P.
- Venue
- Brain Research Reviews
- Publisher
- Elsevier BV
- Published
- 2009-03
- Volume
- 59
- Issue
- 2
- Pages
- 293-315
- ISSN
- 0165-0173 (ISSN-L)
- OpenAlex
- W2116449899
- Cited by
- 574
- References
- 382
- FWCI
- 11.26
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.